Assessed whether engineering pathogens capable of "sustained, human-to-human transmission and causing mortality and morbidity" is possible/probable. Also considers how such pathogens would compare to naturally emergent pathogens in these regards, the…
This report assesses the utility of multi-criteria decision analysis (MCDA) and decision support framework (DSF) in assisting the US Department of Agriculture in its reviews of select agents. It uses the method to assess 41 pathogens against 21…
Author surveys bioweapons experts to roadmap the most important historical trends surrounding bioweapon risk and policy (motivators, inhibitors, drivers, wild cards) from the 1940s to present day. With this information, the author attempts to create…
This article describes BioRAM, a tool to assist biorisk officers in the in the identification, the understanding, and the communication of biorisks present in a laboratory and how to mitigate those risks.
The annual Ready or Not report series tracks states� readiness for public health emergencies based on 10 key indicators that collectively provide a checklist of top-priority issues and action items for states and localities.
The Emerging Threats and Capabilities Subcommittee met to gain a deeper understanding of the nature and severity of biological threats to our security as well as the preparedness to respond to these threats.
This is the third edition of Medical Aspects of Biological Warfare and aims to highlight the current state of science on individual agents and toxins and general response capabilities to prevent knowledge gaps and serve as a reference source for the…
This report describes the types of actions that key federal agencies have taken to develop biological threat awareness, and how that information is used to support investment decisions. It also describes the extent to which these agencies have…
In its Biennial Review, the FESAP considers the removal of Coxiella burnetti, Rickettsi prowasekii, Brucella abortus, Brucella suis, Brucella melitensis, and Bacillus anthracis Pasteur strain from the Select Agents list.
This hearing before the subcommittee on Oversight and Investigations of the Committee on Energy and Commerce of the US Congress discusses the federal governments lack of preparedness to combat naturally occurring outbreaks, laboratory accidents, and…
This report is an historical analysis of US biodefense and bioweapons posture in order to understand the disparity between chemical weapons preparedness and biological weapons preparedness.
This report examines infectious disease preparedness across 10 indicators in each state of the US, in the context of Ebola and preparing for MERS-CoV and other emerging infectious diseases.
This report examines infectious disease preparedness across 10 indicators in each state of the US, particularly in reference to the recent Ebola outbreak.
This hearing before the Subcommittee on Intelligence, Emerging Threats, and Capabilities discussed the threat of biological weapons attacks from state and nonstate actors.
This report examines the status of public health preparedness in the United States following the erosion caused by the financial crisis and ensuing budget cuts.